Effects of Atorvastatin on Endothelial Function, Vascular and Myocardial Redox State in High Cardiovascular Risk Patients.

Trial Profile

Effects of Atorvastatin on Endothelial Function, Vascular and Myocardial Redox State in High Cardiovascular Risk Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Mar 2012

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Atherosclerosis; Cardiovascular disorders; Coronary artery disease; Heart failure; Ischaemic heart disorders
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 16 Nov 2011 Results assessing vascular redox state and nitric oxide bioavailability presented at the 84th Annual Scientific Sessions of the American Heart Association.
    • 31 Aug 2011 Results assessing the effect of treatment on vascular nitric oxide bioavailability presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
    • 31 Aug 2011 Results assessing the effects of treatment on myocardial redox parameters presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top